Bio-Rad Laboratories, Inc. (FRA:BUWA)
272.20
-1.00 (-0.37%)
At close: Dec 4, 2025
Bio-Rad Laboratories Revenue
Bio-Rad Laboratories had revenue of $653.00M USD in the quarter ending September 30, 2025, with 0.51% growth. This brings the company's revenue in the last twelve months to $2.56B, down -0.88% year-over-year. In the year 2024, Bio-Rad Laboratories had annual revenue of $2.57B, down -3.92%.
Revenue (ttm)
$2.56B
Revenue Growth
-0.88%
P/S Ratio
3.37
Revenue / Employee
$332.14K
Employees
7,700
Market Cap
7.34B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.57B | -104.70M | -3.92% |
| Dec 31, 2023 | 2.67B | -131.00M | -4.67% |
| Dec 31, 2022 | 2.80B | -120.35M | -4.12% |
| Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
| Dec 31, 2020 | 2.55B | 233.97M | 10.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Bio-Rad Laboratories News
- 5 weeks ago - Citigroup Raises Price Target for Bio-Rad Laboratories (BIO) to $375 | BIO Stock News - GuruFocus
- 5 weeks ago - Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday - The Motley Fool
- 5 weeks ago - Bio-Rad Laboratories Inc (BIO) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 5 weeks ago - Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Laboratories Inc (BIO) - GuruFocus
- 5 weeks ago - Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Bio-Rad Laboratories Inc (BIO) Q3 Earnings: Revenue Surpasses Estimates at $653M, Non-GAAP EPS ... - GuruFocus
- 5 weeks ago - Bio-Rad Laboratories, Inc. Non-GAAP EPS of $2.26 beats by $0.33, revenue of $653M beats by $1.7M - Seeking Alpha
- 5 weeks ago - Bio-Rad Reports Third-Quarter 2025 Financial Results - Business Wire